Literature DB >> 16463121

Glutamate-induced cell death and formation of radicals can be reduced by lisuride in mesencephalic primary cell culture.

R Moldzio1, K Radad, J C Duvigneau, B Kranner, C Krewenka, C Piskernik, W D Rausch.   

Abstract

Oxidative stress evoked by excitotoxicity is considered an important factor for the loss of dopaminergic neurons in Parkinson's disease. In vitro, protective effects of the dopamine agonist lisuride on complex I inhibition in primary dopaminergic cell culture have been reported. However, little is known about the effects of lisuride on glutamate-induced radical formation. Here, effects of lisuride on the formation of nitric oxide (NO) and superoxide radicals following glutamate exposure were studied on primary cell cultures prepared from mouse mesencephala. Glutamate treatment resulted in doubling of NO and superoxide radical formation, increased dopaminergic cell degeneration and extensively altered neuronal appearance. Pretreatment with lisuride significantly lowered the levels of either reactive species and increased the survival of dopaminergic neurons compared to glutamate-treated cultures. Moreover, the beneficial effect of lisuride could be completely inhibited by the D2/D3 receptor antagonist sulpiride when co-treated in cultures.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16463121     DOI: 10.1007/s00702-005-0394-1

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  45 in total

Review 1.  Glutamate transport and metabolism in dopaminergic neurons of substantia nigra: implications for the pathogenesis of Parkinson's disease.

Authors:  A Plaitakis; P Shashidharan
Journal:  J Neurol       Date:  2000-04       Impact factor: 4.849

2.  Relationships between superoxide levels and delayed calcium deregulation in cultured cerebellar granule cells exposed continuously to glutamate.

Authors:  Sabino Vesce; Liana Kirk; David G Nicholls
Journal:  J Neurochem       Date:  2004-08       Impact factor: 5.372

3.  Direct evidence for expression of dopamine receptors in astrocytes from basal ganglia.

Authors:  Ikuko Miyazaki; Masato Asanuma; Francisco J Diaz-Corrales; Ko Miyoshi; Norio Ogawa
Journal:  Brain Res       Date:  2004-12-10       Impact factor: 3.252

Review 4.  Pathology and biology of the Lewy body.

Authors:  M S Pollanen; D W Dickson; C Bergeron
Journal:  J Neuropathol Exp Neurol       Date:  1993-05       Impact factor: 3.685

5.  Pergolide scavenges both hydroxyl and nitric oxide free radicals in vitro and inhibits lipid peroxidation in different regions of the rat brain.

Authors:  M Gómez-Vargas; S Nishibayashi-Asanuma; M Asanuma; Y Kondo; E Iwata; N Ogawa
Journal:  Brain Res       Date:  1998-04-20       Impact factor: 3.252

Review 6.  Manganese and calcium transport in mitochondria: implications for manganese toxicity.

Authors:  C E Gavin; K K Gunter; T E Gunter
Journal:  Neurotoxicology       Date:  1999 Apr-Jun       Impact factor: 4.294

7.  Ginsenosides Rb1 and Rg1 effects on mesencephalic dopaminergic cells stressed with glutamate.

Authors:  Khaled Radad; Gabriele Gille; Rudolf Moldzio; Hiroshi Saito; Wolf-Dieter Rausch
Journal:  Brain Res       Date:  2004-09-17       Impact factor: 3.252

8.  Vulnerability of oligodendroglia to glutamate: pharmacology, mechanisms, and prevention.

Authors:  A Oka; M J Belliveau; P A Rosenberg; J J Volpe
Journal:  J Neurosci       Date:  1993-04       Impact factor: 6.167

9.  Astroglial plasticity and glutamate function in a chronic mouse model of Parkinson's disease.

Authors:  Adrian G Dervan; Charles K Meshul; Mitchell Beales; Gethin J McBean; Cindy Moore; Susan Totterdell; Ann K Snyder; Gloria E Meredith
Journal:  Exp Neurol       Date:  2004-11       Impact factor: 5.330

Review 10.  Subthalamic nucleus-mediated excitotoxicity in Parkinson's disease: a target for neuroprotection.

Authors:  M C Rodriguez; J A Obeso; C W Olanow
Journal:  Ann Neurol       Date:  1998-09       Impact factor: 10.422

View more
  7 in total

1.  Signaling Mechanisms in the Nitric Oxide Donor- and Amphetamine-Induced Dopamine Release in Mesencephalic Primary Cultured Neurons.

Authors:  Cristiane Salum; Fanny Schmidt; Patrick P Michel; Elaine Del-Bel; Rita Raisman-Vozari
Journal:  Neurotox Res       Date:  2015-09-21       Impact factor: 3.911

2.  L-type Cav1.2 calcium channel is involved in 6-hydroxydopamine-induced neurotoxicity in rats.

Authors:  Rong Wang; Zegang Ma; Jun Wang; Junxia Xie
Journal:  Neurotox Res       Date:  2011-09-07       Impact factor: 3.911

3.  Nifedipine prevents iron accumulation and reverses iron-overload-induced dopamine neuron degeneration in the substantia nigra of rats.

Authors:  ZeGang Ma; Yu Zhou; JunXia Xie
Journal:  Neurotox Res       Date:  2012-01-19       Impact factor: 3.911

4.  Protective effects of resveratrol on glutamate-induced damages in murine brain cultures.

Authors:  Rudolf Moldzio; Khaled Radad; Christopher Krewenka; Barbara Kranner; Johanna Catharina Duvigneau; Wolf-Dieter Rausch
Journal:  J Neural Transm (Vienna)       Date:  2013-03-05       Impact factor: 3.575

5.  Effects of epigallocatechin gallate on rotenone-injured murine brain cultures.

Authors:  Rudolf Moldzio; Khaled Radad; Christopher Krewenka; Barbara Kranner; Johanna Catharina Duvigneau; Yingzi Wang; Wolf-Dieter Rausch
Journal:  J Neural Transm (Vienna)       Date:  2009-08-26       Impact factor: 3.575

6.  Tropism, intracerebral distribution, and transduction efficiency of HIV- and SIV-based lentiviral vectors after injection into the mouse brain: a qualitative and quantitative in vivo study.

Authors:  Juraj Hlavatý; Zbyněk Tonar; Matthias Renner; Sylvia Panitz; Helga Petznek; Matthias Schweizer; Silke Schüle; Björn-Philipp Kloke; Rudolf Moldzio; Kirsti Witter
Journal:  Histochem Cell Biol       Date:  2017-04-10       Impact factor: 4.304

Review 7.  From the tyrosine hydroxylase hypothesis of Parkinson's disease to modern strategies: a short historical overview.

Authors:  Wolf-Dieter Rausch; Feixue Wang; Khaled Radad
Journal:  J Neural Transm (Vienna)       Date:  2022-04-23       Impact factor: 3.850

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.